CDK4 and neoplasm: Of those, the n‐terminal domain plays a key role in the inhibition of tumor growth through the P16/CyclinD/CDK4/RB/E2F pathway, during which dephosphorylation or hypophosphorylation of RB binds to intracellular transcription factor (E2F) and inhibits gene transcription.11